Abstract:The indolizidine alkaloid swainsonine (SW) is a deadly mycotoxin to livestock that can be produced by different plant-associated fungi, including the endophytic entomopathogenic fungi Metarhizium species. The SW biosynthetic gene cluster has been identified but the genetic mechanism of SW biosynthesis remains obscure. To unveil the SW biosynthetic pathway, we performed gene deletions in M. robertsii, heterologous expression of a core biosynthetic gene, substrate feedings, mass spectrometry, and bioassay analyses in this study. It was unveiled that SW is produced via a multibranched pathway by the hybrid nonribosomal peptide–polyketide synthase (NRPS-PKS) gene cluster in M. robertsii. The precursor pipecolic acid can be converted from lysine by both the SW biosynthetic cluster and the unclustered genes such as lysine cyclodeaminase. The hybrid NRPS-PKS enzyme produces three intermediates with and without domain skipping. Intriguingly, the biosynthetic process is coupled with the cis to trans nonenzymatic epimerization of C1-OH for both hydroxyl- and dihydroxyl-indolizidine intermediates. We also found that SW production was dispensable for fungal colonization of plants and infection of insect hosts. Functional characterization of the SW biosynthetic genes in this study may benefit the safe use of Metarhizium fungi as insect biocontrol agents and the management of livestock pastures from SW contamination by genetic manipulation of the toxin-producing fungi.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00466?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00466</a>.Detailed procedures for gene deletion and heterologous expression, SW production, purification and structure analysis of SW intermediates, and fungal interactive assay with plants, as well as additional figures and tables (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00466/suppl_file/cb0c00466_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Research advances in sources and biosynthesis of swainsonine

Advances in Biosynthesis of Swainsonine

The Biosynthesis Pathway of Swainsonine, a New Anticancer Drug from Three Endophytic Fungi.

The biosynthesis pathway of swainsonine, a new anti-cancer drug from three endophytic fungi.

Recent research progress on swainsonine

Research Progress of SWN Gene Cluster in the Synthetic Pathway of Swainsonine

Progress in the Method for Swainsonine Source and Separating Method

Progress on Extraction Technology and Detecting Methods of Swainsonine

Progress on Antineoplastic Activity of Swainsonine

Progress on Anti-tumor Activity of Swainsonine

Isolation and Identification of Swainsonine from Oxytropis Glabra and Its Pathological Lesions to SD Rats

Isolation and NMR Study on Swainsonine from Locoweed, Astragalus Strictus

Clarification of Swainsonine Biosynthesis by a Multi-Branched Pathway and Non-Accumulation of Mycotoxin in Plants after Fungal Colonization

Unveiling of Swainsonine Biosynthesis via a Multibranched Pathway in Fungi

Sesquiterpenoids and Mycotoxin Swainsonine from the Locoweed Endophytic Fungus Alternaria Oxytropis.

Isolation and Identification of Poisonous Constituent Swainsonine from Astragalus variabilis Bunge

Unveiling of Swainsonine Biosynthesis Via a Multi-Branched Pathway in Fungi.

Transcriptomic Screening of Alternaria oxytropis Isolated from Locoweed Plants for Genes Involved in Mycotoxin Swaisonine Production

The Toxicology Mechanism of Endophytic Fungus and Swainsonine in Locoweed

Swainsonine producing performance of <i>Alternaria oxytropis</i> was improved by heavy-ion mutagenesis technology

Ultrasound-assisted solvent extraction of swainsonine from Oxytropis ochrocephala Bunge